Page last updated: 2024-10-31

clorgyline and Cardiovascular Diseases

clorgyline has been researched along with Cardiovascular Diseases in 1 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"Clorgyline and pargyline were used as inhibitors of monoamine oxidase (MAO) A and B, respectively."1.27Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors. ( Cox, LR; Grossman, SL; Ramos, K, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramos, K1
Grossman, SL1
Cox, LR1

Other Studies

1 other study available for clorgyline and Cardiovascular Diseases

ArticleYear
Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
    Toxicology and applied pharmacology, 1988, Volume: 95, Issue:1

    Topics: Acrolein; Aldehydes; Allylamine; Amines; Animals; Benzylamine Oxidase; Cardiovascular Diseases; Cell

1988
chemdatabank.com